vs
ASP Isotopes Inc.(ASPI)与香颂国际控股(CHSN)财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是香颂国际控股的1.9倍($16.7M vs $8.7M),ASP Isotopes Inc.同比增速更快(1295.7% vs 15.2%)
ASP Isotopes Inc.是一家特种材料企业,专注于高纯度定制同位素的研发与生产,产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域,客户覆盖北美、欧洲及亚太地区。
香颂国际控股是一家主营高端烘焙连锁业务的食品企业,核心市场位于中国内地,产品线涵盖新鲜面包、手工糕点、定制庆典蛋糕、特色饮品,同时向合作零售网点供应冷冻烘焙产品,服务追求高品质饮食的中等收入消费群体。
ASPI vs CHSN — 直观对比
营收规模更大
ASPI
是对方的1.9倍
$8.7M
营收增速更快
ASPI
高出1280.5%
15.2%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.7M | $8.7M |
| 净利润 | — | $-1.0M |
| 毛利率 | 12.5% | 44.5% |
| 营业利润率 | — | -13.7% |
| 净利率 | — | -12.1% |
| 营收同比 | 1295.7% | 15.2% |
| 净利润同比 | -586.8% | -4579.7% |
| 每股收益(稀释后) | — | $-2.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPI
CHSN
| Q4 25 | $16.7M | — | ||
| Q3 25 | $4.9M | — | ||
| Q2 25 | — | $8.7M | ||
| Q2 24 | — | $7.5M |
净利润
ASPI
CHSN
| Q4 25 | — | — | ||
| Q3 25 | $-12.9M | — | ||
| Q2 25 | — | $-1.0M | ||
| Q2 24 | — | $23.4K |
毛利率
ASPI
CHSN
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | 44.5% | ||
| Q2 24 | — | 41.5% |
营业利润率
ASPI
CHSN
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | — | ||
| Q2 25 | — | -13.7% | ||
| Q2 24 | — | -7.4% |
净利率
ASPI
CHSN
| Q4 25 | — | — | ||
| Q3 25 | -263.7% | — | ||
| Q2 25 | — | -12.1% | ||
| Q2 24 | — | 0.3% |
每股收益(稀释后)
ASPI
CHSN
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | — | $-2.87 | ||
| Q2 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $22.1M |
| 总债务越低越好 | $14.4M | $4.5M |
| 股东权益账面价值 | $204.2M | $24.5M |
| 总资产 | $498.0M | $51.6M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.18× |
8季度趋势,按日历期对齐
现金及短期投资
ASPI
CHSN
| Q4 25 | $333.3M | — | ||
| Q3 25 | $113.9M | — | ||
| Q2 25 | — | $22.1M | ||
| Q2 24 | — | $4.1M |
总债务
ASPI
CHSN
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | $4.5M | ||
| Q2 24 | — | — |
股东权益
ASPI
CHSN
| Q4 25 | $204.2M | — | ||
| Q3 25 | $74.1M | — | ||
| Q2 25 | — | $24.5M | ||
| Q2 24 | — | $12.1M |
总资产
ASPI
CHSN
| Q4 25 | $498.0M | — | ||
| Q3 25 | $225.9M | — | ||
| Q2 25 | — | $51.6M | ||
| Q2 24 | — | $38.7M |
负债/权益比
ASPI
CHSN
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | 0.18× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-390.3K |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASPI
CHSN
| Q4 25 | $-37.8M | — | ||
| Q3 25 | $-8.9M | — | ||
| Q2 25 | — | $-390.3K | ||
| Q2 24 | — | $806.1K |
自由现金流
ASPI
CHSN
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | $771.9K |
自由现金流率
ASPI
CHSN
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | 10.2% |
资本支出强度
ASPI
CHSN
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | 0.5% |
现金转化率
ASPI
CHSN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | 34.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图